Chinese herbal medicine for infertility with anovulation: A systematic review

Journal of Alternative and Complementary Medicine

Volumn 18, Issue 12, 2012, Pages 1087-1100

  Tan, Li ^a,b   Tong, Yao ^b   Sze, Stephen Cho Wing ^b   Xu, Mei ^a   Shi, Yang ^a   Song, Xin Yang ^c   Zhang, Ting Ting ^a  

^a SHANGHAI UNIVERSITY   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; CHORIONIC GONADOTROPIN; CLOMIFENE; DIETHYLSTILBESTROL; MEDROXYPROGESTERONE;

ANOVULATION; ATOPIC DERMATITIS; CHINA; CHINESE MEDICINE; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FEMALE INFERTILITY; HEADACHE; HEART PALPITATION; HUMAN; INFERTILITY THERAPY; INTERVENTION STUDY; LUTEINIZED UNRUPTURED FOLLICLE SYNDROME; MASTALGIA; META ANALYSIS; NAUSEA; OVARY DISEASE; OVARY HYPERSTIMULATION; OVULATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; URTICARIA; UTERINE CERVIX MUCUS; UTERUS BLEEDING; VOMITING; WEIGHT GAIN; XEROSTOMIA;

ANOVULATION; CERVIX UTERI; CLOMIPHENE; DRUGS, CHINESE HERBAL; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; MUCUS; OVULATION; PHYTOTHERAPY; PREGNANCY; PREGNANCY RATE;

EID: 84870492696     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2011.0371     Document Type: Review

References (73)

1. Kumar A, Ghadir S, Eskandari N, DeCherney AH. Infertility. In: DeCherney AH, Nathan L, Goodwin TM, Laufer N, eds. Current Diagnosis and Treatment. Obstetrics & Gynecology. New York: McGraw Hill, 2007.
2. Juul S, Karmaus W, Olsen J. Regional differences in waiting time to pregnancy: Pregnancy-based surveys from Denmark, France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group. Hum Reprod 1999;14:1250-1254.
3. Olsen J, Kuppers-Chinnow M, Spinelli A. Seeking medical help for subfecundity: A study based upon surveys in five European countries. Fertil Steril 1996;66:95-100.
4. Rutstein SO, Shah IH. Infecundity, Infertility, and Childlessness in Developing Countries. DHS Comparative Reports No. 9. Calverton, MD: ORC Macro and the World Health Organization, 2004.
5. Mosher WD, Pratt WF. Fecundity and infertility in the United States: Incidence and trends. Fertil Steril 1991;56: 192-193.
6. Zhang L-Z. Clinical Reproductive Endocrinology and Infertility. China, Beijing: Science Press, 2001:445.
7. Cedars M, Jaffe RB. Patient information page from the hormone foundation: Infertility and women. J Clin Endocrinol Metab 2005;90:4.
8. Luciano AA, Peluso J, Koch EI, et al. Temporal relationship and reliability of clinical, hormonal, and ultrasonographic indices of ovulation in infertile women. Obstet Gynecol 1990;75:412-416.
9. Wathen NC, Perry L, Lilford RJ, Chard T. Interpretation of single progesterone measurement in diagnosis of anovula-tion and defective luteal phase: Observations on analysis of the normal range. Br Med J 1984;288:7-9.
10. Noyes RW, Hertig AW, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3.
11. de Crespigny LC, O'Herlihy C, Robinson HP. Ultrasonic observation of the mechanism of human ovulation. Am J Obstet Gynecol 1981;139:636-639.
12. Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985;291:1693-1697.
13. Baird DT. Ovulation induction: Current status and future prospects of gonadotrophin therapy. In: Adashi EY, Leung PC, eds. The Ovary. New York: Raven Press, 1993:529-544.
14. Gaware VM, Parjane SK, Merekar Abhijit N, et al. Female infertility and its treatment by alternative medicine: A review. J Chem Pharm Res 2009;1:148-162.
15. MacGregor AH, Johnson JE, Bunde CA. Further clinical experience with clomiphene citrate. Fertil Steril 1968;19:616-622.
16. Hughes E, Collins J, Vandekerckhove P. Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea. Cochrane Database Syst Rev 2000;2:CD000056.
17. Platteau P, Nyboe Andersen A, Balen A, et al. for the Menopur Ovulation Induction (MOI) Study Group. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: A randomized controlled study. Hum Reprod 2006;21:1798-1804.
18. Balen A, Platteau P, Nyboe Andersen A, et al. for the Bravelle Ovulation Induction (BOI) Study Group. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: A randomized controlled non-inferiority trial. Hum Reprod 2007;22:1816-1823.
19. Lee VC, Ledger W. Aromatase inhibitors for ovulation induction and ovarian stimulation. Clin Endocrinol (Oxf) 2011;74:537-46.
20. The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23: 462-477.
21. Derman SG, Adashi EY. Adverse effects of fertility drugs. Drug Saf 1994;11:408-421.
22. Pelinck MJ, Hoek A, Simons AH, Heineman MJ. Efficacy of natural cycle IVF: A review of the literature. Hum Reprod Update 2002;82:129-139.
23. Kashyap S, Moher D, Fung MF, Rosenwaks Z . Assisted reproductive technology and the incidence of ovarian cancer: A meta-analysis. Obstet Gynecol 2004;103:785-794.
24. Ayhan A, Salman MC, Celik H, et al. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers. Acta Obstet Gynecol Scand 2004;83: 1104-1111.
25. Brinton L. Long-term effects of ovulation-stimulating drugs on cancer risk. Reprod Biomed Online 2007;15:38-44.
26. Petignat P, Vassilakos P, Campana A. Are fertility drugs a risk factor for persistent trophoblastic tumour? Hum Reprod 2002;17:1610-1615.
27. Gauthier E, Paoletti X, Clavel-Chapelon F; E3N group. Breast cancer risk associated with being treated for infertility: Results from the French E3N cohort study. Hum Reprod 2004;19:2216-2221.
28. Jensen A, Sharif H, Frederiksen K, Kjaer SK. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. Am J Epidemiol 2009;170:1408-1414.
29. Lerner-Geva L, Rabinovici J, Lunenfeld B. Ovarian stimulation: Is there a long-term risk for ovarian, breast and endometrial cancer? Womens Health (Lond Engl) 2010;6:831-839.
30. Corchia C, Mastroiacovo P, Lanni R, et al. What proportion of multiple births are due to ovulation induction? A registerbased study in Italy. Am J Public Health 1996;86:851-854.
31. Kurinczuk JJ, Hansen M, Bower C. The risk of birth defects in children born after assisted reproductive technologies. Curr Opin Obstet Gynecol 2004;16:201-209.
32. Hansen M, Bower C, Milne E, et al. Assisted reproductive technologies and the risk of birth defects: A systematic review. Hum Reprod 2005;20:328-38.
33. Olson CK, Keppler-Noreuil KM, Romitti PA, et al. In vitro fertilization is associated with an increase in major birth defects. Fertil Steril 2005;84:1308-1315.
34. Zhou J, Qu F. Treating gynaecological disorders with traditional Chinese medicine: A review. Afr J Tradit Complement Altern Med 2009;6:494-517.
35. Huang ST, Chen AP. Traditional Chinese medicine and infertility. Curr Opin Obstet Gynecol 2008,20:211-215.
36. Yan F, Zhang JH, Li RF, Song LP. Integrative Chinese and western medicine approach in treating 64 patients with anovular infertility. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003;9:60-62.
37. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996;347: 569-573.
38. Eisenberg D, David RB, Ettner SL, et al. Trends in alternative medicine use in the United States; 1990-1997. JAMA 1998; 280:1569-1575.
39. Ernst E, White AR. The BBC survey of complementary medicine use in the UK. Complement Ther Med 2000;8: 32-36.
40. Chen G, Shi Y. The development of Chinese Medicine treatment in anovulatory infertility. J Jiangxi Univ Trad Chin Med 2009;21:84-86.
41. Liu Y, Zhou H. Progress of Traditional Chinese Medicine in treating anovulatory infertility. J Liaoning Univ Trad Chin Med 2010;12:280-281.
42. Feng G. Discussion on application mechanism of treating ovulation barriers with Xiaoyao San. Clin J Chin Med 2010; 2:13-14.
43. Han Y, Wang H, Qiao J, et al. Recent developments of Chinese Medicine and Western medicine for treatment of anovulatory infertility. J Liaoning Univ Trad Chin Med 2011;13:5-7.
44. Mao E, Zhou H. Summary on TCM treating ovulation dysfunction infertility. J Liaoning Univ Trad Chin Med 2009; 11:72-74.
45. Mo X, Li D, Pu Y, et al. Clinical studies on the mechanism of acupuncture stimulation of ovulation. J Trad Chin Med 1993;13:115-119.
46. Liu JX, Liu MR, Song T. Clinical and experimental study on the ovulation promoting effect of yangjing decoction. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21:94-98.
47. Yin X, Jiang M, Zuo X. Clinical research of "Shuangzi decoction" in treating anovulatory infertility in 76 cases. Shanghai J Trad Chin Med 2004;38:39-41.
48. Lian F, Wang L, Zhang JW. Effect of erzhi tiangui recipe on ovarian reactivity in elderly sterile women. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006;26:685-688.
49. Li S, Li Y, Chang F. Clinical observation of Yishen Zhuyun granule in treating 120 cases with infertility due to ovulatory dysfunction. J Nanjing Univ Trad Chin Med 2009;25:31-34.
50. Liu D. A comparative study on ovulation decoction in treating ovulation failure barrenness. Clin J Chin Med 2010;2:40-41.
51. Practice Committee of the American Society for Reproductive Medicine. Optimal evaluation of the infertile female. Fertil Steril 2006;86(5 suppl 1):S264-S267.
52. Obstetrics and Gynecology Committee of The China Association of Integrative Medicine the Third Conference. Female Infertility Integrative Medicine standard. Chin J Integr Med 1991;11:378.
53. The Ministry of Health of the People's Republic of China. The Guiding Principles of Chinese Medicine New Drugs Clinical Research (First Series). China, Beijing: China Medical Science Press 1993:276-279.
54. Cui NN, Li GJ. 120 cases of Zhuyun No.1 Tang on ovulatory dysfunction infertility. Shanxi Zhong Yi 2003;24:963-964.
55. Huang TH, Luo L, Ma J, et al. Clinical and experimental research on Ankun Zhongzi Wan on follicle development and ovulation. Gansu Zhong Yi 2006;19:45-47.
56. Liu DF. A comparative study on ovulation decoction in treating ovulation failure barrenness. Clin J Chin Med 2010;15:40-41.
57. Huang YL. 32 cases of Bushen Huayu Tang on ovulatory dysfunction infertility. Shizhen Guo Yi Guo Yao 2007;18: 2237.
58. Qiu LF, Wang J. Clinical observation of TiaoJing Cuyun Wan on ovulatory dysfunction infertility. Guoji Yi Yao Wei Sheng Dao Bao 2004;10:66-67.
59. Pang BZ, Zhao HY. Prospective study of 59 cases on nourish kidney and ovulation. Shanxi Zhong Yi 1997;18:488.
60. Xu XM. 30 cases' clinical observations about the treatment cycle of Bushen Huoxue medicine on ovulatory dysfunction infertility. Chin Health Care 2009;17:789-790.
61. Qiu MY, Luo Q, Zhu LY, et al. Clinical observations of Guilu Bushen capsule on ovulation induction. Liaoning Zhong Yi Za Zhi 2004;31:479-480.
62. Luo ZJ, Zhan J, Wu YY. 182 cases of Tiaozhou Zhongyao Fang on ovulatory dysfunction infertility. Zhongyi Za Zhi 2007; 48:432-433.
63. Chu YX, Wang RJ. 60 cases of Erzi capsule on ovulatory dysfunction infertility. Zhongyi Yan Jiu 2006;19:27-29.
64. Yin XQ, Zuo XM. Clinical research about 160 cases of Bushen Tianjing method on ovulatory dysfunction infertility. Zhonghua Lin Chuang Yi Xue Za Zhi 2006;7:43-44.
65. Yin XQ, Jiang MS, Zuo XM. Clinical research about 76 cases of Shuangzi Tnag on ovulatory dysfunction infertility. Shanghai Zhong Yi Yao Za Zhi 2004;38:39-41.
66. Xia YW, Cai LX, Zhang SC, et al. Therapeutic effect of Chinese herbal medicines for nourishing blood and reinforcing Shen in treating patients with anovulatory sterility of Shen-deficiency type and its influence on the hemodynamics in ovarian and uterine arteries. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24:299-302.
67. Fu J. Clinical analysis about Chinese herbal medicines of Zhongyao Zhuyun Wan on ovulatory dysfunction infertility. Henan Zhong Yi Xue Yuan Xue Bao 2007;22:51-52.
68. Huang J. Clinical observation of nourish kidney on ovulatory dysfunction infertility. Zhejiang Zhong Xi Yi Jie He Za Zhi 2002;12:577-578.
69. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
70. Zhang M. Chinese mechanism and integrative medicine for ovulatory infertility research progress. Gansu J Trad Chin Med 2007;20:70-72.
71. Gao X, Gao Y, Feng J. Clinical research of Traditional Chinese Medicine for ovulatory infertility. J Changchun Univ Trad Chin Med 2007;23:107-108.
72. Chen G, Shi Y. The development of Chinese Medicine treatment in anovulatory infertility. J Jiangxi Univ Trad Chin Med 2009;21:84-86.
73. Xu L, Luo S. Pathogenesis of ovulation disorders. Chin J Infor TCM 2003;10:4.